Dies ist eine HTML Version eines Anhanges der Informationsfreiheitsanfrage 'TTIP lobbying'.



Ref. Ares(2015)5006757 - 11/11/2015
Ref. Ares(2016)6036878 - 20/10/2016
To: 
 (GROW); 
 (GROW); 
 (TRADE) 
Cc: 
 (TRADE); 
 (TRADE) 
Subject: 
TTIP and Cosmetics phone call with Cosmetics Europe on 02/07/2015 
 
 
DG TRADE and GROW officials discussed TTIP and Cosmetics with Cosmetics 
Europe on 02/07/2015 
 
•  COM noted that main difficulty remains the fact that several products (e.g. 
sunscreens) are classified in the US as Over the Counter Drugs (OTCs) 
whereas in the EU they are classified as cosmetics. This leads to very 
different assessment and approval procedures. US is unlikely to change the 
definition of cosmetics. It is also not clear if it is possible to distinguish 
between primary and secondary functions of UV filters. There were some 
initiatives from the US consumers that pleaded for a faster approval of UV 
filters in the US. The EU position paper of March 2015 is still valid. There is 
no legal text available.  
•  Cosmetics Europe noted that the US Sunscreen Innovation Act does not 
define what scientific data will be required to prove safety of UV filters. This 
will be done later by means of FDA guidance 
•  A pilot project on a concrete UV-filter already approved in the EU (including 
the data submitted) but not yet in the US could be developed (It could be 
however challenging to identify a UV filter + address teh human resources 
needed) 
•  Cosmetics Europe enquired why allergens would be put forward as a TTIP 
discussion area. COM clarified regulatory cooperation in new/non regulated 
areas is useful. There is however no particular regulatory objective. 
•  As regards harmonization of labelling requirements, the financial benefit 
seems to be limited 
 
Participants: 

 (DG TRADE);  

 (DG GROW) 
Gerard Renner (Cosmetics Europe) 
 
 
European Commission 
Directorate General for Trade